Gene · 8671
Papers1,389
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,389
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting SLC4A4: A Novel Approach in Colorectal Cancer Drug Repurposing. | Curr Issues Mol Biol | 2025 | 39852182 | PubTator, text mining | PubMed |
| Depth-corrected multi-factor dissection of chromatin accessibility for scATAC-seq data with PACS. | Nat Commun | 2025 | 39757254 | PubTator, text mining | PubMed |
| SLC4A4 Moulds the Inflammatory Tumor Microenvironment and Predicts Therapeutic Expectations in Colorectal Cancer. | Curr Med Chem | 2025 | 38310390 | PubTator, text mining | PubMed |
| Single-cell atlas of transcriptomic vulnerability across multiple neurodegenerative and neuropsychiatric diseases. | medRxiv | 2024 | 41602098 | PubTator, text mining | PubMed |
| On the substrate turnover rate of NBCe1 and AE1 SLC4 transporters: structure-function considerations. | Front Physiol | 2024 | 39872416 | PubTator, text mining | PubMed |
| Dissecting the novel molecular interactions of solute carrier family 4 member 4 (SLC4A4) for prostate cancer (PCa) progression. | Sci Rep | 2024 | 39587129 | PubTator, text mining | PubMed |
| Reimagining the meninges from a neuroimmune perspective: a boundary, but not peripheral. | J Neuroinflammation | 2024 | 39548515 | PubTator, text mining | PubMed |
| Solute carrier family 4 member 4 (SLC4A4) is associated with cell proliferation, migration and immune cell infiltration in colon cancer. | Discov Oncol | 2024 | 39467887 | PubTator, text mining | PubMed |
| Fabrication and characteristics of new quaternized chitosan nanocapsules loaded with thymol or thyme essential oil as effective SARS-CoV-2 inhibitors. | RSC Adv | 2024 | 39285882 | PubTator, text mining | PubMed |
| Left Ventricular Systolic Dysfunction in NBCe1-B/C-Knockout Mice. | Int J Mol Sci | 2024 | 39273556 | PubTator, text mining | PubMed |
| Enhancing soil health, microbial count, and hydrophilic methomyl and hydrophobic lambda-cyhalothrin remediation with biochar and nano-biochar. | Sci Rep | 2024 | 39174647 | PubTator, text mining | PubMed |
| SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression. | Int Immunopharmacol | 2024 | 39083932 | PubTator, text mining | PubMed |
| Identification of Polymorphisms in EAAT1 Glutamate Transporter Gene SLC1A3 Associated with Reduced Migraine Risk. | Genes (Basel) | 2024 | 38927733 | PubTator, text mining | PubMed |
| SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer. | Cancer Lett | 2024 | 38880227 | PubTator, text mining | PubMed |
| Identification and Validation of SLC9A2 as A Potential Tumor Suppressor in Colorectal Cancer: Integrating Bioinformatics Analysis with Experimental Confirmation. | Curr Med Sci | 2024 | 38809379 | PubTator, text mining | PubMed |
| SLC38A3 Promotes the Proliferation and Migration of Tumor Cells and Predicts Poor Prognosis in Colorectal Cancer. | ACS Omega | 2024 | 38764627 | PubTator, text mining | PubMed |
| A traditional Korean fermented food, Gochujang exerts anti-hypertensive effects, regardless of its high salt content by regulating renin-angiotensin-aldosterone system in SD rats. | Heliyon | 2024 | 38726141 | PubTator, text mining | PubMed |
| Astrocytic Slc4a4 regulates blood-brain barrier integrity in healthy and stroke brains via a CCL2-CCR2 pathway and NO dysregulation. | Cell Rep | 2024 | 38709635 | PubTator, text mining | PubMed |
| The electroneutral Na+-HCO3- cotransporter NBCn1 (SLC4A7) modulates colonic enterocyte pHi, proliferation, and migration. | Am J Physiol Cell Physiol | 2024 | 38646790 | PubTator, text mining | PubMed |
| Antibodies toward Na+,HCO3--cotransporter NBCn1/SLC4A7 block net acid extrusion and cause pH-dependent growth inhibition and apoptosis in breast cancer. | Br J Cancer | 2024 | 38310186 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8671/papers?page=3